Scapa Group

Scapa Group
Name	Scapa Group
Type	Public (formerly)
Industry	Manufacturing
Founded	1937
Fate	Acquired 2019
Headquarters	Birmingham, United Kingdom
Products	Adhesives, tapes, medical dressings, bonding solutions
Revenue	£340 million (2018)
Num employees	~2,600 (2018)

Scapa Group

Scapa Group was a British multinational manufacturer specializing in adhesive bonding solutions, industrial tapes and medical dressings. Founded in 1937 and headquartered in Birmingham, the company supplied customers across automotive, healthcare, aerospace and industrial markets, with operations spanning Europe, North America and Asia. Scapa became notable for serving clients in sectors such as Jaguar Land Rover, Rolls-Royce plc, NHS suppliers and original equipment manufacturers before its acquisition in 2019.

History

Scapa Group began in 1937 during the interwar years, expanding through wartime manufacturing and postwar industrial growth linked to companies like Vickers-Armstrongs and Birmingham City suppliers. During the late 20th century the company broadened via acquisitions and product diversification amid trends exemplified by Dunlop Rubber consolidation and the rise of specialist manufacturers such as 3M and Avery Dennison. In the 1990s and 2000s Scapa executed strategic purchases to enter medical and industrial adhesive markets, following models similar to Smith & Nephew and Johnson & Johnson. Scapa listed on the London Stock Exchange and weathered globalisation pressures, competing with multinationals including Henkel and Nitto Denko. In the 2010s its trajectory paralleled industry peers consolidating through mergers and private equity deals, culminating in acquisition by Berry Global Group in 2019.

Products and Services

Scapa produced a range of adhesive-based products and ancillary services. Core product lines included pressure-sensitive tapes, double-sided bonding tapes, foam tapes and coated films used by manufacturers such as Ford Motor Company, BAE Systems and Airbus. In healthcare, Scapa manufactured wound care dressings and ostomy products serving clients within the NHS supply chain and private providers like Bupa. The company offered engineered adhesive solutions for aerospace and automotive applications—markets also served by companies such as Hexcel and Magneti Marelli—providing surface protection films, vibration control tapes and gasketing materials. Scapa’s services extended to custom formulation, technical support, and just-in-time logistics modelled on practices from Walton Group-style supply chains.

Operations and Facilities

Scapa’s operational footprint encompassed manufacturing sites, R&D centres and sales offices across multiple regions. European facilities included plants in the United Kingdom and mainland Europe, interacting with industrial clusters like West Midlands and suppliers to OEMs such as Rolls-Royce plc and McLaren Automotive. North American operations served markets via plants in the United States and Canada, supplying clients including General Motors and regional healthcare networks; these operations resembled manufacturing footprints maintained by 3M subsidiaries. Asian presence provided proximity to electronics and automotive manufacturers in regions where firms like Foxconn and Toyota Motor Corporation operate. Research and development focused on adhesive chemistry, polymer science and materials engineering, collaborating with academic institutions comparable to University of Birmingham and Imperial College London research groups.

Financial Performance

Scapa reported revenues fluctuating with global manufacturing cycles, foreign exchange and raw material costs. In the late 2010s the company’s annual revenue was in the low hundreds of millions of pounds, with profitability influenced by consolidation pressures evident in sectors dominated by Saint-Gobain and Dow Inc.. Scapa’s stock performance on the London Stock Exchange reflected investor responses to operational restructuring, divestments and acquisition activity. Financial metrics were affected by capital investments in production capacity, working capital tied to large OEM contracts from companies such as Jaguar Land Rover and exposure to commodity price swings similar to movements experienced by BASF.

Corporate Governance and Ownership

Scapa operated as a publicly listed company with a board of directors overseeing strategy, risk and compliance in accordance with codes referenced by institutions like the Financial Reporting Council. Executive leadership comprised a chief executive, finance director and divisional heads with backgrounds in manufacturing and industrial distribution, paralleling executives from firms such as Smiths Group and Melrose Industries. Shareholder composition included institutional investors, corporate funds and individual shareholders typical of UK-listed industrials, until acquisition by Berry Global Group in 2019 which resulted in private ownership under a multinational packaging and materials conglomerate.

Environmental, Health and Safety Practices

Scapa implemented environmental, health and safety (EHS) systems addressing chemical handling, solvent emissions and workplace safety, aligning practices with standards observed by manufacturers like Henkel and 3M. Compliance activities included waste management, emissions monitoring and occupational health measures for workers at production facilities clustered in regions such as West Midlands and North American industrial states. The company undertook product stewardship for adhesives and medical materials to meet regulatory requirements similar to those enforced by bodies like the Medicines and Healthcare products Regulatory Agency and regional environmental agencies; initiatives covered supply-chain sustainability, recycling efforts and reductions in volatile organic compound emissions.

Category:Manufacturing companies of the United Kingdom Category:Companies established in 1937 Category:Business services companies of the United Kingdom